Reyes-Marín FA

Language: Spanish
References: 16
Page: 517-519
PDF size: 34.87 Kb.

ABSTRACT

Continuous therapy and hemodialysis are specials kinds of renal replacement therapies, they have supported patients with chronic and acute renal diseases, and have allowed decreased morbimortality and improved quality of life in these population of patients. In the last 20 years have been described technological advances in this field, we have new hemodialysis machines and devices: filters, lines and have been showed new filters with human proximal tubular cells, from deceased donor kidneys not suitable for transplantation because of excessive fibrosis, they allow better ultrafiltration rates and improve clearance of toxins, cytokines and electrolytes. In spite of the fact, technological advances, clinical research indicates that the mortality is high in patients with acute renal failure and continuous therapy and when two modalities of dialytic treatment: hemodialysis and hemodiafiltration were compared in randomized studies, the mortality was similar in both groups and only recovery time in days, volume control and improved in clearance of cytokines were better in hemodiafiltration.

REFERENCES

1. Kramer P, Wigger W, Rieger J. Arteriovenous hemofiltration: A new and simple method for treatment of overhydrated patients resistant to diuretics. Klin Wochenschr 1977;55:1121-1129.

2. Lauer A, Saccggi A, Ronco C. Continuous arteriovenous hemofiltration in the critically ill patients. Ann Intern Med 1983;99:455-500.

3. Ronco C, Brendolan A, Bragantini L. Continuous arteriovenous hemofiltration. Contrib Nephrol 1985;48:70-78.

4. Geronemus R, Schneider N. Continuous arteriovenous hemodialysis: A new modality for treatment of acute renal failure. Trans Am Soc Artif Intern Organs 1984;30:610-615.

5. Bellomo R, Parkin G, Love J. Management of acute renal failure in the critically ill with continuous hemovenous hemodiafiltration. Ren Fail 1992;14:183-186.

6. Ronco C. Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients. Clin Nephrol 1993;40:187-198.

7. Grootendorst AF, Van Boomel AF, Van Der Hoven B. High volume ultrafiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992;18:235-240.

8. Bellomo R, Tipping P, Boyce N. Continuous venovenous hemofiltration with dialysis remove cytokines from the circulation of septic patients. Crit Care Med 1993;21:522-526.

9. Palevsky PM, Murray PT. Acute kidney injury and critical care nephrology. NephSAP 2007;6:325-330.

10. Vinsonneau C, Camus C, Combes A. Continuous venovenous hemodiafiltration versus intermittent hemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomized trial. Lancet 2006;368:379-385.

11. Cho KC, Himmelfarb J, Paganini E. Survival by dialysis modality in critically ill patients with acute kidney injury. J Am Soc Nephrol 2006;17:3132-3138.

12. Tonelli M, Manns B, Feller Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002;40:875-885.

13. Humes HD, Weitzel WF, Bartlett RH. Initial clinical results of the bioartificial kidney containing human cells in ICU patients with acute renal failure. Kidney Int 2004;66:1578-1588.

14. Humes HD, Weitzel WF, Bartlett RH. Renal cell therapy is associated with dynamic and individualized responses in patients with acute renal failure. Blood Purif 2003;21:64-71.

15. Davenport A, Gura V, Ronco C. A wearable haemodialysis device for patients with end stage renal failure: A pilot study. Lancet 2007;370:2005-2010.

16. Culleton BF, Walsh M, Klarenbach S. Effect of frequent nocturnal hemodialysis vs. conventional hemodialysis on left ventricular mass and quality of life. JAMA 2008;298:1291-1300.